Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic susceptibility testing for hereditary breast and ovarian cancer--approach from a commercial clinical laboratory].

Rinsho byori. The Japanese journal of clinical pathology - 1 Sept 2002

Shoji Shigeru, Gondo Nobuhisa

Abstract excerpt

Genetic testing for hereditary cancers and other common diseases are still considered as the research testing, not for the clinical testing in Japan. One of the major reason of this situation is related to the guidelines regarding the human genetic testing issued successively in the spring of 2001, one by joint work of the eight learned societies and the other by the Japan clinical laboratories association. Both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Forecasting
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Laboratories

Share to Ovarian Neoplasms

Share to Social Environment

Share to United States

Source

Identifiers

PMID: 12386965

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic susceptibility testing for hereditary breast and ovarian cancer--approach from a commercial clinical laboratory].PMID 12386965Read ↗

[Genetic testing for cancer susceptibility: the present situation in Japan].Semantic proximity Read ↗

Efficacy of clinical guidelines in identifying all Japanese patients with hereditary breast and ovarian cancerSemantic proximity Read ↗

[Establishment of the germline genetic testing system in the laboratory medicine].Semantic proximity Read ↗

[Diagnosis of Hereditary Tumors Using Multi Gene Panel Testing(MGPT)-Current Status and Issues in Japan or Worldwide].Semantic proximity Read ↗

[A review on genetic testing].Semantic proximity Read ↗

[Heredity and cancer].Semantic proximity Read ↗

[Genetic diagnosis of familial breast cancer].Semantic proximity Read ↗

[Progress in the gene research on hereditary breast cancer-ovarian cancer].Semantic proximity Read ↗

[Genetic counseling and practice of hereditary cancers at Shikoku Cancer Center].Semantic proximity Read ↗

[Cancer genetic predisposition: current events and perspectives in 2010].Semantic proximity Read ↗

Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.Semantic proximity Read ↗

[Gene mutation and genetic counseling].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.